Company / Working Capital per Share
SELLAS Life Sciences Group, Inc. Working Capital per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$0.11
FY2024
5-year range
-$0.50 / $4.84
FY2020-FY2024
Trend
+122.1%
vs FY2023
Sector context
#203 of 210
Health Care
What the data says
Among 210 Health Care companies, SELLAS Life Sciences Group, Inc. is in the bottom 3% for working capital per share. Working Capital per Share returned to growth in FY2024 after 3 years of decline, reaching $0.11.
Based on SEC 10-K filings.
0.11 in FY2024 with a 5-year CAGR of -37.3%.
Declined from $0.14 to $0.11 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -55.5%
- 5-Year CAGR
- -37.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 210This company $0.11 Sector average $146.86
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2024, working capital per share increased 122.1% year-over-year.
- Ranks #203 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2020.
- Lowest working capital per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.11 | +122.1% |
| FY2023 | -$0.50 | -456.7% |
| FY2022 | $0.14 | -88.9% |
| FY2021 | $1.27 | -73.8% |
| FY2020 | $4.84 | +319.5% |
| FY2019 | $1.15 | +321.9% |
| FY2018 | -$0.52 | +89.4% |
| FY2017 | -$4.91 | -6495.5% |
| FY2016 | $0.08 | +343.3% |
| FY2015 | -$0.03 | -113.9% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026